Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CRISPR Therapeutics AG - Common Shares
(NQ:
CRSP
)
51.10
-0.01 (-0.02%)
Streaming Delayed Price
Updated: 12:01 PM EST, Nov 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
888,205
Open
49.58
Bid (Size)
51.00 (100)
Ask (Size)
51.20 (100)
Prev. Close
51.11
Today's Range
49.11 - 51.64
52wk Range
30.04 - 78.48
Shares Outstanding
78,935,098
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
ARK Sold Almost 400,000 Shares of CRISPR Therapeutics. Is Cathie Wood Worried?
↗
November 12, 2025
ARK Sold Almost 400,000 Shares of CRISPR Therapeutics. Is Cathie Wood Worried?
Via
The Motley Fool
Topics
Regulatory Compliance
CRISPR Therapeutics' Investigational Gene Therapy Shows Promising Lipid-Lowering Effects In Early Trial
↗
November 11, 2025
CRISPR Therapeutics' CTX310 trial shows strong, sustained lipid reductions and favorable safety, boosting confidence in its gene editing platform.
Via
Benzinga
Performance
YTD
+23.3%
+23.3%
1 Month
-26.3%
-26.3%
3 Month
-13.1%
-13.1%
6 Month
+40.7%
+40.7%
1 Year
+2.6%
+2.6%
More News
Read More
Why Gene-Editing Giants Crispr And Intellia Just Surged
↗
November 10, 2025
Via
Investor's Business Daily
Topics
Death
Retail Bulls Call CRISPR ‘Criminally Undervalued’ After Gene-Editing Breakthrough Cuts Cholesterol By 70%
↗
November 10, 2025
Via
Stocktwits
Intellia Therapeutics Crashes After A Patient In Its Pivotal Study Dies
↗
November 07, 2025
Via
Investor's Business Daily
Topics
Death
How Is The Market Feeling About CRISPR Therapeutics?
↗
September 12, 2025
Via
Benzinga
AI Unlocks Gene-Editing Revolution: $2 Million Grant Propels Disease Cures
November 06, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Climate Change
Intellectual Property
Cathie Wood Goes All-In On Peter Thiel's Crypto Play Bullish With Back-To-Back Million-Dollar Buys
↗
November 04, 2025
Via
Benzinga
AI Unleashes a New Era in Cell and Gene Therapy: A Quarter Century Update Reveals Transformative Potential
November 04, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Prediction: 2 Stocks That Will Be Worth More Than SoundHound AI 2 Years From Now
↗
November 04, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Intellia Freezes Key Trial After Serious Liver Event, Stock Tumbles
↗
October 27, 2025
Via
Benzinga
2 Soaring Cathie Wood Stocks to Buy and Hold
↗
October 17, 2025
Via
The Motley Fool
New to Growth Stocks? Here's 1 Every Investor Should Have on Their Radar.
↗
October 16, 2025
Via
The Motley Fool
3 Monster Stocks to Hold for the Next 10 Years
↗
October 15, 2025
Via
The Motley Fool
4 Healthcare Stocks to Buy Now
↗
October 12, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
10 Health Care Stocks Whale Activity In Today's Session
↗
October 08, 2025
Via
Benzinga
Healthcare Stocks Are Rising: Here Are 2 With Even More Upside Ahead
↗
October 08, 2025
Via
The Motley Fool
Topics
Government
World Trade
Navigating the Future: Unlocking Investment Opportunities in High-Growth Sectors
October 04, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Climate Change
Economy
10 Health Care Stocks Whale Activity In Today's Session
↗
October 03, 2025
Via
Benzinga
3 Growth Stocks That Could Be 10-Baggers in 10 Years
↗
October 03, 2025
Via
The Motley Fool
Got $200? 2 Healthcare Stocks to Buy and Hold Forever
↗
October 01, 2025
Via
The Motley Fool
Could This Beaten-Down Stock Help You Become a Millionaire?
↗
September 30, 2025
Via
The Motley Fool
Topics
ETFs
The Pharmaceutical Revolution: AI, Gene Therapies, and Obesity Drugs Reshape a Trillion-Dollar Market
September 19, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
My Top Biotech Stock Picks And Portfolio Strategy For The Next 3-10 Years
↗
September 18, 2025
Via
Benzinga
Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises
September 18, 2025
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Frequently Asked Questions
Is CRISPR Therapeutics AG - Common Shares publicly traded?
Yes, CRISPR Therapeutics AG - Common Shares is publicly traded.
What exchange does CRISPR Therapeutics AG - Common Shares trade on?
CRISPR Therapeutics AG - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for CRISPR Therapeutics AG - Common Shares?
The ticker symbol for CRISPR Therapeutics AG - Common Shares is CRSP on the Nasdaq Stock Market
What is the current price of CRISPR Therapeutics AG - Common Shares?
The current price of CRISPR Therapeutics AG - Common Shares is 51.10
When was CRISPR Therapeutics AG - Common Shares last traded?
The last trade of CRISPR Therapeutics AG - Common Shares was at 11/14/25 12:01 PM ET
What is the market capitalization of CRISPR Therapeutics AG - Common Shares?
The market capitalization of CRISPR Therapeutics AG - Common Shares is 4.03B
How many shares of CRISPR Therapeutics AG - Common Shares are outstanding?
CRISPR Therapeutics AG - Common Shares has 4B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.